<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01437163</url>
  </required_header>
  <id_info>
    <org_study_id>ApiraTH655</org_study_id>
    <nct_id>NCT01437163</nct_id>
  </id_info>
  <brief_title>Treatment of Androgenetic Alopecia in Males and Females</brief_title>
  <acronym>LLLT</acronym>
  <official_title>The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Apira Science, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Apira Science, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of Low Level Laser and Light Therapy
      system configured in a novel product called the TopHat 655 system, for promoting hair growth
      in males and females diagnosed with androgenetic alopecia of the head.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Increase of Terminal Hairs from Pre-treatment, Baseline Count</measure>
    <time_frame>After 16 weeks of therapy</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Androgenetic Alopecia</condition>
  <arm_group>
    <arm_group_label>Red Incandescent light source</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>TopHat 655</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TopHat 655 rejuvenation system</intervention_name>
    <description>TopHat 655 system is to be applied every other day for 16 weeks for a pre-programmed time period</description>
    <arm_group_label>TopHat 655</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser and/or Light Hair Rejuvenation System</intervention_name>
    <description>A red incandescent light source replaces all lasers and light emitting diodes.</description>
    <arm_group_label>Red Incandescent light source</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of androgenetic alopecia

          -  Fitzpatrick Skin Phototypes I-IV

          -  Norwood-Hamilton IIa to V for males and Ludwig I or II for females

          -  Active hair loss within the last 12 months

          -  Willingness to refrain from using all other hair growth products or treatments

          -  In overall general good health as determined by the physician investigator

        Exclusion Criteria:

          -  Photosensitivity to laser light and non-laser LED light operating at 655nms.

          -  Malignancy in the target treatment area

          -  Other forms of alopecia of the head

          -  Past medical history of a collagen-vascular disease, thyroid disease or other
             cutaneous or systemic disease that seriously effects the scalp

          -  Unwillingness to remove hair replacement products during the therapy sessions

          -  Using any medications deemed to inhibit hair growth as determined by the physician
             investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond J. Lanzafame, MD</last_name>
    <role>Study Director</role>
    <affiliation>Raymond J. Lanzafame, MD</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter S. Halperin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peter S. Halperin, MD</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adolfo Fernandez-Obregon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Adolfo Fernandez-Obregon, MD</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey A Sklar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Aesthetic Dermatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Adolfo Fernandez-Obregon, MD</name>
      <address>
        <city>Hoboken</city>
        <state>New Jersey</state>
        <zip>07030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peter S. Halperin, MD</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Raymond J. Lanzafame, MD</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jeffrey A. Sklar, MD</name>
      <address>
        <city>Woodbury</city>
        <state>New York</state>
        <zip>11797</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2011</study_first_submitted>
  <study_first_submitted_qc>September 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2011</study_first_posted>
  <last_update_submitted>July 11, 2016</last_update_submitted>
  <last_update_submitted_qc>July 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

